In addition, exogenous IL-6 treatment restored Treg proportions in PBMCs cocultured with Agrin-deficient NSCLC cells, while the addition of IL-6 antibodies significantly decreased the percentages of Tregs in PBMCs (Figures 6E–G). This evidence concerns the gene IL6 and non-small cell lung carcinoma.